GlassScriptPhysician profile
Cole Milliken
NPI 1477110799
$16,710.32
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $329 · 2021: $757 · 2022: $1,272 · 2023: $612 · 2024: $1,033 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,300 · Food and Beverage: $4,727 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,300.00 |
| Food and Beverage | $4,726.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $325.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $8,966.77 | 2020-2025 | Voyager Dslt, Clareon Panoptix Pro, Acrysof Iq Panoptix Uv Iol |
| Tarsus Pharmaceuticals, INC. | $1,598.43 | 2025 | Xdemvy |
| Glaukos Corporation | $1,275.44 | 2022-2025 | Idosetr, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Biotissue Holdings INC. | $867.62 | 2024-2025 | |
| Abbvie INC. | $700.68 | 2022-2025 | |
| Alcon Research LLC | $650.00 | 2025 | Viscoat |
| New World Medical,INC. | $603.98 | 2024-2025 | Clearpath, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Bausch & Lomb Americas INC. | $413.53 | 2022-2025 | Xiidra, Miebo, Stellaris |
| Rxsight INC | $261.24 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Sun Pharmaceutical Industries INC. | $255.07 | 2023-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $248.98 | 2020-2025 | Acthar |
| Sight Sciences, INC. | $205.30 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.53 | 2021 | |
| Genentech USA, INC. | $137.54 | 2022-2023 | Vabysmo |
| Allergan, INC. | $118.13 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $76.46 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $73.44 | 2024 | Retina Workplace |
| Oyster Point Pharma, INC. | $53.17 | 2025 | Ryzumvi, Tyrvaya |
| Harrow Eye, LLC | $21.76 | 2025 | Vevye |
| Rayner Intraocular Lenses Limited | $16.46 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Johnson & Johnson Surgical Vision, INC. | $15.79 | 2025 | Tecnis Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cole Milliken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.